SCHEMBL25709568

SCHEMBL25709568

N#Cc1ccc2cc(-c3ccc(-c4nc(-c5ccc(C67C[C@H]8C[C@H](C6)C[C@@H](C7)C8)cc5)cc(-c5ccc(C67C[C@H]8C[C@H](C6)C[C@@H](C7)C8)cc5)n4)cc3)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 10/20 0.41
▸ CYP11B1 P15538 2/20 0.40
▸ CYP11B2 P19099 2/20 0.40
▸ CYP17A1 P05093 1/20 0.40
▸ RARB P10826 5/20 0.39
▸ RARG P13631 5/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ RARA P10276 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25709924 0.96 CYP17A1 (0.42) PGRCYP11B1CYP11B2CYP17A1RARB
SCHEMBL25709096 0.96 CYP17A1 (0.42) PGRCYP11B1CYP11B2CYP17A1RARB
SCHEMBL25709422 0.94 PGR (0.47) PGRCYP11B1CYP11B2CYP17A1RARB
SCHEMBL25710135 0.94 PGR (0.47) PGRCYP11B1CYP11B2CYP17A1RARB
SCHEMBL25710223 0.94 PGR (0.47) PGRCYP11B1CYP11B2CYP17A1RARB
SCHEMBL25719905 0.92 CYP11B1 (0.36) PGRCYP11B1CYP11B2CYP17A1RARB
SCHEMBL25710124 0.90 PGR (0.48) PGRCYP11B1CYP11B2CYP17A1RARB
SCHEMBL25709410 0.90 PGR (0.48) PGRCYP11B1CYP11B2CYP17A1RARB
SCHEMBL25709095 0.90 CYP17A1 (0.44) PGRCYP11B1CYP11B2CYP17A1RARB
SCHEMBL25709927 0.90 CYP17A1 (0.44) PGRCYP11B1CYP11B2CYP17A1RARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11746093-B2 Nitrogen-containing compound, electronic element, and electronic device SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-09-05 — — US disclosed
US-20230192627-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11746093-B2 Nitrogen-containing compound, electronic element, and electronic device SLC43A1, SLC7A5, L1CAM PGR 3470/4885CYP11B1 3598/4885CYP11B2 3007/4885
US-20230192627-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SLC43A1, SLC7A5, L1CAM PGR 3470/4885CYP11B1 3598/4885CYP11B2 3007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback